Authors:
Wiemels, JL
Smith, RN
Taylor, GM
Eden, OB
Alexander, FE
Greaves, MF
Citation: Jl. Wiemels et al., Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia, P NAS US, 98(7), 2001, pp. 4004-4009
Authors:
Alexander, FE
Patheal, SL
Biondi, A
Brandalise, S
Cabrera, ME
Chan, LC
Chen, Z
Cimino, G
Cordoba, JC
Gu, LJ
Hussein, H
Ishii, E
Kamel, AM
Labra, S
Magalhaes, IQ
Mizutani, S
Petridou, E
de Oliveira, MP
Yuen, P
Wiemels, JL
Greaves, MF
Citation: Fe. Alexander et al., Transplacental chemical exposure and risk of infant leukemia with MLL genefusion, CANCER RES, 61(6), 2001, pp. 2542-2546
Authors:
Smith, MT
Wang, YX
Kane, E
Rollinson, S
Wiemels, JL
Roman, E
Roddam, P
Cartwright, R
Morgan, G
Citation: Mt. Smith et al., Low NAD(P)H : quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults, BLOOD, 97(5), 2001, pp. 1422-1426
Citation: Jl. Wiemels et M. Greaves, Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia, CANCER RES, 59(16), 1999, pp. 4075-4082
Authors:
Wiemels, JL
Pagnamenta, A
Taylor, GM
Eden, OB
Alexander, FE
Greaves, MF
Citation: Jl. Wiemels et al., A lack of a functional NAD(P)H : quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions, CANCER RES, 59(16), 1999, pp. 4095-4099
Authors:
Wiemels, JL
Ford, AM
Van Wering, ER
Postma, A
Greaves, M
Citation: Jl. Wiemels et al., Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero, BLOOD, 94(3), 1999, pp. 1057-1062